BDBM412513 (Z)-N-(5-(1-(4-bromophenyl)prop-1- en-1-yl)pyrazin-2-yl)-5-fluoro-4- methylnicotinamide::US10399967, Compound 146
SMILES: C\C=C(\c1ccc(Br)cc1)c1cnc(NC(=O)c2cncc(F)c2C)cn1
InChI Key: InChIKey=LPNGUNKXNPYWTD-CQPUUCJISA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interleukin-2 (Homo sapiens (Human)) | BDBM412513 ((Z)-N-(5-(1-(4-bromophenyl)prop-1- en-1-yl)pyrazin...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
PRCL RESEARCH INC. US Patent | Assay Description Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti... | US Patent US10399967 (2019) BindingDB Entry DOI: 10.7270/Q2Z89FRQ | |||||||||||
More data for this Ligand-Target Pair |